- Home
- LGMK vs SNOA Comparison
LGMK vs SNOA Comparison
Compare LGMK & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGMK
- SNOA
- Stock Information
- Founded
- LGMK 2011
- SNOA 1999
- Country
- LGMK United States
- SNOA United States
- Employees
- LGMK N/A
- SNOA N/A
- Industry
- LGMK Industrial Specialties
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- LGMK Health Care
- SNOA Health Care
- Exchange
- LGMK Nasdaq
- SNOA Nasdaq
- Market Cap
- LGMK 3.6M
- SNOA 3.6M
- IPO Year
- LGMK N/A
- SNOA 2007
- Fundamental
- Price
- LGMK $0.26
- SNOA $2.40
- Analyst Decision
- LGMK
- SNOA
- Analyst Count
- LGMK 0
- SNOA 0
- Target Price
- LGMK N/A
- SNOA N/A
- AVG Volume (30 Days)
- LGMK 1.6M
- SNOA 52.9K
- Earning Date
- LGMK 03-26-2025
- SNOA 02-05-2025
- Dividend Yield
- LGMK N/A
- SNOA N/A
- EPS Growth
- LGMK N/A
- SNOA N/A
- EPS
- LGMK N/A
- SNOA N/A
- Revenue
- LGMK $10,078,502.00
- SNOA $13,973,000.00
- Revenue This Year
- LGMK $1.54
- SNOA $23.89
- Revenue Next Year
- LGMK N/A
- SNOA $25.45
- P/E Ratio
- LGMK N/A
- SNOA N/A
- Revenue Growth
- LGMK 4.44
- SNOA 13.51
- 52 Week Low
- LGMK $0.25
- SNOA $2.30
- 52 Week High
- LGMK $32.25
- SNOA $9.40
- Technical
- Relative Strength Index (RSI)
- LGMK 11.06
- SNOA 36.06
- Support Level
- LGMK $0.25
- SNOA $2.30
- Resistance Level
- LGMK $0.73
- SNOA $2.62
- Average True Range (ATR)
- LGMK 0.08
- SNOA 0.12
- MACD
- LGMK -0.05
- SNOA -0.02
- Stochastic Oscillator
- LGMK 0.77
- SNOA 21.59
About LGMK LogicMark Inc. (NV)
LogicMark Inc provides personal emergency response systems (PERS), health communications devices, and IoT technologies to create a connected care platform. Its devices give people the ability to receive care at home and confidence to age in place. The company incorporates two-way voice communication technology directly into its medical alert pendant and provides this life-saving technology at a price point that everyday consumers can afford.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.